Since the expression levels of p32 have been found higher in cancer cells with respect to those in normal cells (Chen et al., 2009; Rubinstein et al., 2004), our results are of significance in relation to the key role of p32 in disabling p53 function during cancer development. The gene discussed is TP53; the disease is cancer.